A high-level delegation led by South Sudan’s Undersecretary of Health visited Yei River State to intensify Ebola preparedness in the country
The objective of the visit was to among others reassure local authorities of the continued support of the development partners and the one UN in South Sudan
Ebola Virus Disease (EVD) is one of the most fatal and highly infectious diseases known to the world
On 15 July 2019, a high-level delegation led by Dr Makur Matur Kariom, Undersecretary, Ministry of Health and Mr Alain Noudehou, UN Resident/Humanitarian Coordinator and comprising Ambassadors of donor countries, heads of United Nations (UN) agencies and Representatives of international non-governmental organizations visited Yei town.
The objective of the visit was to among others reassure local authorities of the continued support of the development partners and the one UN in South Sudan; secure sustained commitment of the local authorities to the EVD preparedness efforts and publicize in the national press key messages to the general public regarding Ebola preparedness.
South Sudan is one of the four priority one countries (Burundi, Rwanda, South Sudan, Uganda) prioritized by WHO to enhance preparedness and operational readiness based on the proximity to the outbreak area as well as the capacity to manage Ebola virus disease (EVD) outbreaks in the Democratic Republic of Congo (DRC).
The risk of transmission of EVD into countries that share borders with DRC, including South Sudan, has been classified as “very high” by WHO. Cases of EVD have recently been confirmed in Uganda, Goma and in Ariwara, a town in DRC located just 70km from the border with South Sudan.
“Diseases such as Ebola don’t respect boundaries, race or religion so all must ensure that they work together to prevent its cross border transmission into South Sudan”, said Mr Noudehou. He also reiterated the commitment of the UN to continue to support EVD preparedness in the country under the leadership of WHO.
As a priority one country for EVD preparedness, the Ministry of Health, National Task Force, WHO and partners are implementing the National EVD Preparedness Plan, including vaccinating front-line health workers, educating people about prevention and response measures, conducting screening at multiple locations to help with early detection of cases, training personnel in infection prevention and control as well as being preparing for safe and dignified burial processes if needed.
“Although South Sudan has not confirmed any EVD case, implementation of effective public health measures is critical to manage the risk posed by South Sudan’s complex humanitarian context, the history of previous (EVD) outbreaks, increasing global travel and proximity to DRC”, said Dr Olushayo Olu, WHO Country Representative to South Sudan.
At the end of the visit, the Governor of the state, the state Health Ministry and partners on the ground reiterated their commitment to intensify key interventions and increase public awareness by providing adequate information through all communication channels, religious and community leaders.
In his closing remarks, the Undersecretary, Dr Makur appreciated WHO and other partners for the strong partnership and support rendered to enhance capacities to effectively implement the International Health Regulations (IHR, 2005) and address the threats of EVD and other infectious diseases.
Ebola Virus Disease (EVD) is one of the most fatal and highly infectious diseases known to the world. The on-going outbreak in the Democratic Republic of Congo (DRC) is the second largest outbreak reported globally. As of 13 July 2019, 2 489 confirmed cases and 1 665 deaths have been reported.
WHO is working in Jubek, Gbudue, Tambura, Maridi, Torit, Wau and Yei River states alongside their respective state health ministries and partners to provide strategic public health leadership and support required to ensure that all the high-risk counties are operationally ready and prepared to implement timely and effective EVD risk mitigation, detection, and response measures.
Distributed by APO Group on behalf of World Health Organization (WHO).